Navigation Links
Treating Prostate Cancer: Old School vs. New School
Date:8/24/2009

The historically low cure rates offered by traditional radiotherapy and proton therapy are being replaced by almost unbelievable treatment outcomes from the combination of modern brachytherapy and IMRT

Mesa, AZ (Vocus) August 24, 2009 -- New innovations in treating prostate cancer have more than doubled the cure rate for high-risk patients. Traditional proton and photon therapies have an approximate 40% success rate for patients with advanced prostate cancer. In sharp contrast, new combined therapies discussed on Doctorfinders.com, have shown cure rates as high as 98% for patients in expert hands.

An estimated 234,000 new cases of prostate cancer will be diagnosed in the United States this year, making it one of the most common cancers affecting American men, second only to skin cancer. More than 27,000 deaths due to prostate cancer are expected to occur this year.

Prostate cancer is most often diagnosed through a blood test measuring the amount of prostate specific antigens (PSA) in the body. However, signs and symptoms of prostate cancer can include: Changes in urinary flow: frequency, urgency, and hesitancy. Also, frequent nighttime urination, painful urination, or blood in urine.

The good news is that the outlook for men diagnosed with prostate cancer is better than ever. When prostate cancer is detected early, while the tumor is still localized, the survival rate is extremely high.

Dr. Jamie Cesaretti, a prostate cancer specialist with the Florida Radiation Oncology Group and contributor to Doctorfinders.com says, "It is an exciting time in prostate cancer radiotherapy treatment. Old concepts of radiotherapy using standard treatments have largely been replaced with new more precise therapies called image-guided brachytherapy (seed-implants) and/or intensity modulation radiation therapy (IMRT)."

The historically low cure rates offered by traditional radiotherapy and proton therapy are being replaced by almost unbelievable treatment outcomes from the combination of modern brachytherapy and IMRT. "A combination of brachytherapy and IMRT can cure between 98% for low-risk patients, 95% for intermediate risk and 85% for high risk patients in expert hands," says Dr. Cesaretti.

The concept behind the combination treatment is simple; the brachytherapy seed implant causes a minimum amount of symptoms while still targeting the cancer. In addition, the IMRT treatment dose is also lowered to also decrease symptoms. In combination, the two high-tech treatments punish the cancer while leaving most men with an excellent quality of life in terms of their ability to have and maintain an erection and live without bowel and bladder symptoms.

Dr. Cesaretti and his partners perform over 500 prostate seed implants per year. He has a special interest in the treatment of prostate cancer with a combination of IMRT and brachytherapy. Dr. Cesaretti's profile can be found at Doctorfinders.com.

DoctorFinders.com is an innovative tool that allows the general public to easily access information about health concerns and find the right doctor for their needs. The site allows for users to identify doctors by geographic area, specialties, procedures, and more.

###

Read the full story at http://www.prweb.com/releases/Doctors/Prostate_Cancer/prweb2786414.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Study finds low risk in treating previously coiled aneurysm
2. Night home hemodialysis shown to be as good as transplant in treating kidney failure
3. Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the Tipping Point in Treating Pressure Ulcers
4. HIV-Treating Clinicians Support Health Care Reform, Express Caution
5. Surgery, Sham Equal in Treating Compression Fracture Pain
6. Genetic testing may be valuable in treating colorectal cancer
7. Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop
8. Lumenis UltraPulse TotalFX Treatment Featured on ABCNews 20/20 as a Secret Weapon for Treating for Burn Scars
9. 'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer
10. Antidepressants aid electroconvulsive therapy in treating severe depression
11. Study in Nature: MicroRNAs hold promise for treating diseases in blood vessels
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Treating Prostate Cancer: Old School vs. New School 
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & ... (TGIG), has initiated cultivation and processing operations at its production facility, and opened ... , Puradigm is the manufacturer of a complete system of proactive air and ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a ... cells and other difficult to transfect cells, announces its launch of the PluriQ™ ... Gene Editing System is a complete system for culturing and transfecting human ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
Breaking Medicine Technology: